Medical News

---

• Spinal manipulation ‘does not benefit asthma patients’
• Pesticides linked to adult-onset asthma in farmers
• DC expression of maturation molecules increases with COPD severity
• Psychosis outcomes and symptoms linked to temperament
• Bipolar concentration problems predict employment status
• Chemotherapy-induced leucopenia linked to amenorrhea in young women
• Moderate exercise can reduce side effects of hormone therapy for prostate cancer
• CETP inhibition may not lower CVD risk
• Key mediator of lipid-induced endoplasmic reticulum stress identified
• Macrovascular complications linked to low productivity, increased healthcare costs
• Glucose intolerance in pregnancy increases risk for metabolic syndrome
• Improvements to FRS risk prediction may be overstated
• Enzyme replacement improves cardiac endpoints in Fabry’s disease patients

Spinal manipulation ‘does not benefit asthma patients’ Posted: 02 Dec 2009 04:00 PM PST A systematic review of published studies has found no evidence to suggest that spinal manipulation improves lung function or reduces respiratory symptoms in people with asthma.

Pesticides linked to adult-onset asthma in farmers Posted: 02 Dec 2009 04:00 PM PST Occupational exposure to certain pesticides is associated with an increased risk for adult-onset asthma in male farmers, results of a US study show.

DC expression of maturation molecules increases with COPD severity Posted: 02 Dec 2009 04:00 PM PST Chronic obstructive pulmonary disease progression is associated with increased expression of maturation molecules by lung dendritic cells, research shows.

Psychosis outcomes and symptoms linked to temperament Posted: 02 Dec 2009 04:00 PM PST Both symptoms and functional outcomes among psychosis patients are associated with temperament traits, conclude European investigators.

Bipolar concentration problems predict employment status Posted: 02 Dec 2009 04:00 PM PST Self-reported concentration problems predict whether or not bipolar I disorder patients achieve stable employment, the results of a study indicate.

Chemotherapy-induced leucopenia linked to amenorrhea in young women Posted: 01 Dec 2009 04:00 PM PST A lower leukocyte count after treatment with fluorouracil, epirubicin, and cyclophosphamide is associated with an increased risk for amenorrhea in young, premenopausal women with breast cancer, study findings indicate.

Moderate exercise can reduce side effects of hormone therapy for prostate cancer Posted: 01 Dec 2009 04:00 PM PST A brief program of resistance and aerobic exercise significantly relieves the adverse effects of androgen suppression therapy in prostate cancer patients, researchers report.

CETP inhibition may not lower CVD risk Posted: 01 Dec 2009 04:00 PM PST Low plasma cholesteryl ester transfer protein activity is associated with increased cardiovascular disease risk, show study results.

Key mediator of lipid-induced endoplasmic reticulum stress identified Posted: 01 Dec 2009 04:00 PM PST Reducing lipotoxic endoplasmic reticulum stress in macrophages by targeting the lipid chaperone aP2 ameliorates atherosclerosis, a study in mice has found.

Macrovascular complications linked to low productivity, increased healthcare costs Posted: 01 Dec 2009 04:00 PM PST Patients with diabetes and macrovascular comorbid conditions have significantly higher healthcare costs and miss more days of work than other diabetics, show study results.

Glucose intolerance in pregnancy increases risk for metabolic syndrome Posted: 01 Dec 2009 04:00 PM PST Women who experience gestational diabetes mellitus or even the milder condition gestational glucose intolerance are at increased risk for developing the metabolic syndrome as little as 3 months after giving birth, say researchers.

Improvements to FRS risk prediction may be overstated Posted: 01 Dec 2009 04:00 PM PST Studies claiming improved prediction of coronary heart disease risk by addition of a novel candidate risk predictor to the Framingham risk score may be unreliable, report researchers in the Journal of the American Medical Association.

Enzyme replacement improves cardiac endpoints in Fabry’s disease patients Posted: 01 Dec 2009 04:00 PM PST Enzyme replacement therapy over a 5-year period reduced cardiac mass and dysfunction as well as decreasing pain and improving quality-of-life measures in patients with Fabry's disease, according to an observational study of registry data.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610